Showing 2,673 results

Filters Content type: News, Editors' picks, About HIV Topic: Hepatitis & HIV

Hepatitis A, B and C are viral infections that can damage the liver and cause serious illnesses. Co-infection with HIV and hepatitis B or C is quite common. Safe and effective treatments are available.

New & experimental hepatitis C treatment

After Patient's Death, Study Shows HCV Drug Cardiotoxic in 14 of 34 Treated Patients

Editor's pick
Medscape (requires registration)
29 September 2014
New & experimental hepatitis C treatment

Patent landscape for hepatitis issued by WHO

Editor's pick
Intellectual Property Watch
29 September 2014
New & experimental hepatitis C treatment

European CHMP Adopts Positive Opinion for Gilead’s Harvoni® (Ledipasvir/Sofosbuvir) for the Treatment of Chronic Hepatitis C Infection in Adults

Editor's pick
Gilead press release
29 September 2014
Hepatitis C treatment

Why Gilead’s Recent Deal with Generic Producers for its Hepatitis C Drugs (Sofosbuvir and Ledipasvir) is a Sham

Editor's pick
ITPC
25 September 2014
Hepatitis C treatment

NICE consults on draft guidance on the drug simeprevir (Olysio) for treating hepatitis C

Editor's pick
NICE
25 September 2014
Hepatitis C treatment

As Gilead Mulls Price of Next Hepatitis C Drug, Top Activist Refutes "Bogus" Math

Editor's pick
TheBody.com
24 September 2014
Hepatitis C symptoms & diagnosis

HCV antibody testing may miss recent infections in gay men living with HIV

News
23 September 2014
Hepatitis C treatment

Hepatitis C: Sit in of European patients to request access to new medicines, on occasion of the informal meeting of European Health Ministers in Milan

Editor's pick
EATG
22 September 2014
Hepatitis C treatment

The new $84,000 hepatitis C treatment is losing momentum, for now

Editor's pick
Washington Post
22 September 2014
Epidemiology & behaviour

STIs and Hep C levels at all-time high in Australia

Editor's pick
Gay News Network
22 September 2014
Hepatitis C symptoms & diagnosis

People living with HIV in the US are infrequently screened for HCV

News
22 September 2014
Hepatitis C treatment

Thousands register for new hepatitis C drug in Egypt sold at 99 percent discount

Editor's pick
Egyptian Streets
19 September 2014
Hepatitis C treatment

Community Leaders, HIV Doctors Oppose Hepatitis C Treatment Barriers

Editor's pick
HIVandhepatitis.com
17 September 2014
Access to healthcare

Gilead’s Proposed Hepatitis C Medicines License: How Badly Will it Miss the Target?

Editor's pick
Infojustice
17 September 2014
Hepatitis C treatment

Access to sofosbuvir in middle-income countries

Editor's pick
I-MAK
17 September 2014
Kidney problems

Study Dampens HOPE of HIV Organ Donations

Editor's pick
Medscape (requires registration)
17 September 2014
Hepatitis C symptoms & diagnosis

Uncovering cases of early HCV infection in HIV-positive men

Editor's pick
CATIE
17 September 2014
Hepatitis C treatment

Gilead Deal to Sell Sovaldi in Poor Countries Meets Criticism

Editor's pick
Pharmalot
16 September 2014
Hepatitis C treatment

Clash between state, drugmaker heats up as Legislature takes up Hepatitis C cost

Editor's pick
The Oregonian
16 September 2014
Hepatitis C treatment

Gilead signs pact with 7 firms for cheap copies of hepatitis C drug

Editor's pick
Reuters
15 September 2014
New & experimental hepatitis C treatment

AbbVie 3D hepatitis C regimen is well-tolerated in Phase 3 trials

Editor's pick
HIVandHepatitis.com
15 September 2014
Pharmaceutical industry

Gilead to raise price for new hepatitis C drug above $84000

Editor's pick
Reuters
15 September 2014
Hepatitis C treatment

Simeprevir in hepatitis C: added benefit for certain patients

Editor's pick
German Institute for Quality and Efficiency in Health Care
10 September 2014
Access to healthcare

Gilead close to sending $84,000 drug to poor countries

Editor's pick
Bloomberg
9 September 2014